T1	Participants 91 184	patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase
T2	Participants 413 484	patients with newly diagnosed chronic myeloid leukemia in chronic phase
T3	Participants 518 530	476 patients
